APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anti-Tuberculosis Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Anti-Tuberculosis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173965470331 December 2025187 pages

Choose your research edition.

Industry ResearchAnti-Tuberculosis Drug Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Tuberculosis Drug Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Anti-Tuberculosis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Tuberculosis Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Tuberculosis Drug Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Anti-Tuberculosis Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Anti-Tuberculosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-Tuberculosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Tuberculosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anti-Tuberculosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-Tuberculosis Drug include Abbott, Sanofi, NOVARTIS, Prizer, Otsuka and Lupin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-Tuberculosis Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-Tuberculosis Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-Tuberculosis Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-Tuberculosis Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-Tuberculosis Drug Segment by Company

Abbott

Sanofi

NOVARTIS

Prizer

Otsuka

Lupin

Anti-Tuberculosis Drug Segment by Type

First-Line Anti-Tuberculosis Drugs

Second-Line Anti-Tuberculosis Drugs

Anti-Tuberculosis Drug Segment by Application

Hospital

Clinic

Others

Anti-Tuberculosis Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Tuberculosis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Tuberculosis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Tuberculosis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-Tuberculosis Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-Tuberculosis Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Anti-Tuberculosis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Anti-Tuberculosis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Anti-Tuberculosis Drug Industry Trends Table 2. Anti-Tuberculosis Drug Industry Drivers Table 3. Anti-Tuberculosis Drug Industry Opportunities and Challenges Table 4. Anti-Tuberculosis Drug Industry Restraints Table 5. Global Anti-Tuberculosis Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Anti-Tuberculosis Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Anti-Tuberculosis Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Anti-Tuberculosis Drug Sales Market Share by Manufacturers Table 9. Global Anti-Tuberculosis Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Anti-Tuberculosis Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Anti-Tuberculosis Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Anti-Tuberculosis Drug Manufacturers, Product Type & Application Table 13. Global Anti-Tuberculosis Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-Tuberculosis Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of First-Line Anti-Tuberculosis Drugs Table 17. Major Manufacturers of Second-Line Anti-Tuberculosis Drugs Table 18. Global Anti-Tuberculosis Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Anti-Tuberculosis Drug Sales by Type (2021-2026) & (K Units) Table 20. Global Anti-Tuberculosis Drug Sales by Type (2027-2032) & (K Units) Table 21. Global Anti-Tuberculosis Drug Sales Market Share by Type (2021-2026) Table 22. Global Anti-Tuberculosis Drug Sales Market Share by Type (2027-2032) Table 23. Global Anti-Tuberculosis Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Anti-Tuberculosis Drug Revenue by Type (2021-2026) & (K Units) Table 25. Global Anti-Tuberculosis Drug Revenue by Type (2027-2032) & (K Units) Table 26. Global Anti-Tuberculosis Drug Revenue Market Share by Type (2021-2026) Table 27. Global Anti-Tuberculosis Drug Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Others Table 31. Global Anti-Tuberculosis Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Anti-Tuberculosis Drug Sales by Application (2021-2026) & (K Units) Table 33. Global Anti-Tuberculosis Drug Sales by Application (2027-2032) & (K Units) Table 34. Global Anti-Tuberculosis Drug Sales Market Share by Application (2021-2026) Table 35. Global Anti-Tuberculosis Drug Sales Market Share by Application (2027-2032) Table 36. Global Anti-Tuberculosis Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Anti-Tuberculosis Drug Revenue by Application (2021-2026) & (K Units) Table 38. Global Anti-Tuberculosis Drug Revenue by Application (2027-2032) & (K Units) Table 39. Global Anti-Tuberculosis Drug Revenue Market Share by Application (2021-2026) Table 40. Global Anti-Tuberculosis Drug Revenue Market Share by Application (2027-2032) Table 41. Global Anti-Tuberculosis Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Anti-Tuberculosis Drug Sales by Region (2021-2026) & (K Units) Table 43. Global Anti-Tuberculosis Drug Sales Market Share by Region (2021-2026) Table 44. Global Anti-Tuberculosis Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Anti-Tuberculosis Drug Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Anti-Tuberculosis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Anti-Tuberculosis Drug Sales by Country (2021-2026) & (K Units) Table 48. North America Anti-Tuberculosis Drug Sales by Country (2027-2032) & (K Units) Table 49. Europe Anti-Tuberculosis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Anti-Tuberculosis Drug Sales by Country (2021-2026) & (K Units) Table 51. Europe Anti-Tuberculosis Drug Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Anti-Tuberculosis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Anti-Tuberculosis Drug Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Anti-Tuberculosis Drug Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Anti-Tuberculosis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Anti-Tuberculosis Drug Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Anti-Tuberculosis Drug Sales by Country (2027-2032) & (K Units) Table 58. Global Anti-Tuberculosis Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Anti-Tuberculosis Drug Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Anti-Tuberculosis Drug Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Anti-Tuberculosis Drug Revenue Market Share by Region (2021-2026) Table 62. Global Anti-Tuberculosis Drug Revenue Market Share by Region (2027-2032) Table 63. Abbott Company Information Table 64. Abbott Business Overview Table 65. Abbott Anti-Tuberculosis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Abbott Anti-Tuberculosis Drug Product Portfolio Table 67. Abbott Recent Development Table 68. Sanofi Company Information Table 69. Sanofi Business Overview Table 70. Sanofi Anti-Tuberculosis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sanofi Anti-Tuberculosis Drug Product Portfolio Table 72. Sanofi Recent Development Table 73. NOVARTIS Company Information Table 74. NOVARTIS Business Overview Table 75. NOVARTIS Anti-Tuberculosis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. NOVARTIS Anti-Tuberculosis Drug Product Portfolio Table 77. NOVARTIS Recent Development Table 78. Prizer Company Information Table 79. Prizer Business Overview Table 80. Prizer Anti-Tuberculosis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Prizer Anti-Tuberculosis Drug Product Portfolio Table 82. Prizer Recent Development Table 83. Otsuka Company Information Table 84. Otsuka Business Overview Table 85. Otsuka Anti-Tuberculosis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Otsuka Anti-Tuberculosis Drug Product Portfolio Table 87. Otsuka Recent Development Table 88. Lupin Company Information Table 89. Lupin Business Overview Table 90. Lupin Anti-Tuberculosis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Lupin Anti-Tuberculosis Drug Product Portfolio Table 92. Lupin Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Anti-Tuberculosis Drug Distributors List Table 96. Anti-Tuberculosis Drug Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Anti-Tuberculosis Drug Product Image Figure 2. Global Anti-Tuberculosis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Tuberculosis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Tuberculosis Drug Sales (2021-2032) & (K Units) Figure 5. Global Anti-Tuberculosis Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Anti-Tuberculosis Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. First-Line Anti-Tuberculosis Drugs Image Figure 9. Second-Line Anti-Tuberculosis Drugs Image Figure 10. Global Anti-Tuberculosis Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Anti-Tuberculosis Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Anti-Tuberculosis Drug Sales Market Share by Type (2021-2032) Figure 13. Global Anti-Tuberculosis Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Anti-Tuberculosis Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Anti-Tuberculosis Drug Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Others Image Figure 19. Global Anti-Tuberculosis Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Anti-Tuberculosis Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Anti-Tuberculosis Drug Sales Market Share by Application (2021-2032) Figure 22. Global Anti-Tuberculosis Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Anti-Tuberculosis Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Anti-Tuberculosis Drug Revenue Market Share by Application (2021-2032) Figure 25. North America Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Anti-Tuberculosis Drug Sales Market Share by Country (2021-2032) Figure 27. U.S. Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Anti-Tuberculosis Drug Sales Market Share by Country (2021-2032) Figure 32. Germany Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Anti-Tuberculosis Drug Sales Market Share by Country (2021-2032) Figure 39. China Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Anti-Tuberculosis Drug Sales Market Share by Country (2021-2032) Figure 47. Brazil Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Anti-Tuberculosis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Anti-Tuberculosis Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Anti-Tuberculosis Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Anti-Tuberculosis Drug Revenue (2021-2032) & (US$ Million) Figure 58. North America Anti-Tuberculosis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Anti-Tuberculosis Drug Revenue (2021-2032) & (US$ Million) Figure 60. Europe Anti-Tuberculosis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Anti-Tuberculosis Drug Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Anti-Tuberculosis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Anti-Tuberculosis Drug Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Anti-Tuberculosis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Anti-Tuberculosis Drug Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Anti-Tuberculosis Drug Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • First-Line Anti-Tuberculosis Drugs
  • Second-Line Anti-Tuberculosis Drugs
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Abbott
  • Sanofi
  • NOVARTIS
  • Prizer
  • Otsuka
  • Lupin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anti-Tuberculosis Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anti-Tuberculosis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Anti-Tuberculosis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Anti-Tuberculosis Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Anti-Tuberculosis Drug Market Dynamics
  1. 2.1 Anti-Tuberculosis Drug Industry Trends
  2. 2.2 Anti-Tuberculosis Drug Industry Drivers
  3. 2.3 Anti-Tuberculosis Drug Industry Opportunities and Challenges
  4. 2.4 Anti-Tuberculosis Drug Industry Restraints
3 Anti-Tuberculosis Drug Market by Manufacturers
  1. 3.1 Global Anti-Tuberculosis Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Anti-Tuberculosis Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Anti-Tuberculosis Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Anti-Tuberculosis Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-Tuberculosis Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Anti-Tuberculosis Drug Manufacturers, Product Type & Application
  7. 3.7 Global Anti-Tuberculosis Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-Tuberculosis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-Tuberculosis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-Tuberculosis Drug Tier 1, Tier 2, and Tier 3
4 Anti-Tuberculosis Drug Market by Type
  1. 4.1 Anti-Tuberculosis Drug Type Introduction
  2. 4.1.1 First-Line Anti-Tuberculosis Drugs
  3. 4.1.2 Second-Line Anti-Tuberculosis Drugs
  4. 4.2 Global Anti-Tuberculosis Drug Sales by Type
  5. 4.2.1 Global Anti-Tuberculosis Drug Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Anti-Tuberculosis Drug Sales by Type (2021-2032)
  7. 4.2.3 Global Anti-Tuberculosis Drug Sales Market Share by Type (2021-2032)
  8. 4.3 Global Anti-Tuberculosis Drug Revenue by Type
  9. 4.3.1 Global Anti-Tuberculosis Drug Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Anti-Tuberculosis Drug Revenue by Type (2021-2032)
  11. 4.3.3 Global Anti-Tuberculosis Drug Revenue Market Share by Type (2021-2032)
5 Anti-Tuberculosis Drug Market by Application
  1. 5.1 Anti-Tuberculosis Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Anti-Tuberculosis Drug Sales by Application
  6. 5.2.1 Global Anti-Tuberculosis Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anti-Tuberculosis Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Anti-Tuberculosis Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Anti-Tuberculosis Drug Revenue by Application
  10. 5.3.1 Global Anti-Tuberculosis Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Anti-Tuberculosis Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Anti-Tuberculosis Drug Revenue Market Share by Application (2021-2032)
6 Global Anti-Tuberculosis Drug Sales by Region
  1. 6.1 Global Anti-Tuberculosis Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-Tuberculosis Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-Tuberculosis Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Anti-Tuberculosis Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anti-Tuberculosis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Anti-Tuberculosis Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Anti-Tuberculosis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Anti-Tuberculosis Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Anti-Tuberculosis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Anti-Tuberculosis Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Anti-Tuberculosis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Anti-Tuberculosis Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Anti-Tuberculosis Drug Revenue by Region
  1. 7.1 Global Anti-Tuberculosis Drug Revenue by Region
  2. 7.1.1 Global Anti-Tuberculosis Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Anti-Tuberculosis Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Anti-Tuberculosis Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Anti-Tuberculosis Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Anti-Tuberculosis Drug Revenue (2021-2032)
  8. 7.2.2 North America Anti-Tuberculosis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Anti-Tuberculosis Drug Revenue (2021-2032)
  11. 7.3.2 Europe Anti-Tuberculosis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Anti-Tuberculosis Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Anti-Tuberculosis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Anti-Tuberculosis Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Anti-Tuberculosis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Anti-Tuberculosis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Anti-Tuberculosis Drug Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Anti-Tuberculosis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Anti-Tuberculosis Drug Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 NOVARTIS
  14. 8.3.1 NOVARTIS Company Information
  15. 8.3.2 NOVARTIS Business Overview
  16. 8.3.3 NOVARTIS Anti-Tuberculosis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 NOVARTIS Anti-Tuberculosis Drug Product Portfolio
  18. 8.3.5 NOVARTIS Recent Developments
  19. 8.4 Prizer
  20. 8.4.1 Prizer Company Information
  21. 8.4.2 Prizer Business Overview
  22. 8.4.3 Prizer Anti-Tuberculosis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Prizer Anti-Tuberculosis Drug Product Portfolio
  24. 8.4.5 Prizer Recent Developments
  25. 8.5 Otsuka
  26. 8.5.1 Otsuka Company Information
  27. 8.5.2 Otsuka Business Overview
  28. 8.5.3 Otsuka Anti-Tuberculosis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Otsuka Anti-Tuberculosis Drug Product Portfolio
  30. 8.5.5 Otsuka Recent Developments
  31. 8.6 Lupin
  32. 8.6.1 Lupin Company Information
  33. 8.6.2 Lupin Business Overview
  34. 8.6.3 Lupin Anti-Tuberculosis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lupin Anti-Tuberculosis Drug Product Portfolio
  36. 8.6.5 Lupin Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-Tuberculosis Drug Value Chain Analysis
  2. 9.1.1 Anti-Tuberculosis Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-Tuberculosis Drug Production Mode & Process
  6. 9.2 Anti-Tuberculosis Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-Tuberculosis Drug Distributors
  9. 9.2.3 Anti-Tuberculosis Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst